Awareness of Clinical Research Coordinators Toward Ethics and Protection of Clinical Trial Patients

被引:3
|
作者
Peng, Zhen [1 ]
Ma, Yan [1 ]
Wang, Jumei [1 ]
Xu, Xiaoling [1 ]
Wang, Chongwei [1 ]
Chen, Yin [1 ]
机构
[1] Univ Sci & Technol China, Affiliated Hosp 1, Div Life Sci & Med, Div Life Sci & Med, Hefei 230001, Anhui, Peoples R China
关键词
Clinical trial; Clinical research coordinators; Ethics; Protection; Knowledge; RESEARCH NURSES; POTENTIAL CONTRIBUTION; JOB-SATISFACTION; INVESTIGATORS; PERCEPTIONS; EDUCATION;
D O I
10.1007/s43441-022-00488-9
中图分类号
R-058 [];
学科分类号
摘要
Purpose Clinical research coordinators (CRCs) play an important role in the protection of clinical trial participants and maintenance of ethical standards. However, limited data are available on the ethical cognition of CRCs. Understanding the knowledge, attitude, and practices (KAP) of CRCs toward ethics is essential to protect study participants and improve their compliance. Methods We conducted a descriptive, cross-sectional, quantitative study at 20 hospitals in Anhui province of China. A self-administered questionnaire was completed by 435 CRCs conducting clinical trials. Results The good knowledge, positive attitude, and good practice rates were 55.2%, 59.3%, and 79.5% respectively. Most CRCs (99.1%) were aware of the participants' rights. Only 127 (29.2%) and 140 (32.2%) CRCs were aware of measures to protect participants' rights and ethical guidelines regarding trials, respectively. In total, 59.6% of CRCs stated that ethical review might delay the start of a clinical trial. Marital status (odds ratio [OR] 0.47, 95% confidence interval [CI] 0.27-0.83), CRC work experience (OR 0.11, 95% CI 0.02-0.75), and educational background (OR 0.31, 95% CI 0.13-0.76) affected the knowledge of CRCs regarding ethics. Conclusions Some deficiencies were observed in the ethical knowledge and behavior of CRCs. Interventions to improve the ethical training of CRCs regarding study participant protection, international guidelines, and the role of ethical committees are essential when conducting clinical trials. Validated instruments should be constructed to assess the effectiveness of ethical training and measure the KAP of CRCs toward ethics.
引用
收藏
页码:561 / 569
页数:9
相关论文
共 50 条
  • [41] Influence of Clinical Research Investigator Fraud on Clinical Trial Participation
    Garimella, Purnachandra
    Martin, Irwin G.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2013, 47 (01) : 90 - 94
  • [42] Need for Ethics Approval and Patient Consent in Clinical Research
    Bath, Philip M. W.
    Watson, Alan R.
    STROKE, 2009, 40 (05) : 1555 - 1556
  • [43] The ethics of clinical research in the era of COVID-19
    Vitti, Juliana N.
    Vitti, Robert
    Chu, Karen
    Mellis, Scott
    FRONTIERS IN PUBLIC HEALTH, 2024, 12
  • [44] COVID-19 vaccines: a look at the ethics of the clinical research involving children
    Cabiedes-Miragaya, Laura
    Galende-Dominguez, Ines
    JOURNAL OF MEDICAL ETHICS, 2022, 48 (10) : 666 - 671
  • [45] Comparison of COVID-19 studies registered in the clinical trial platforms: A research ethics analysis perspective
    Buruk, Banu
    Guner, Muberra Devrim
    Ekmekci, Perihan Elif
    Celebi, Aksuyek Savas
    DEVELOPING WORLD BIOETHICS, 2022, 22 (04) : 217 - 230
  • [46] COVID-19 clinical trial participation and awareness in Texas
    Luningham, Justin M.
    Akpan, Idara N.
    Alkhatib, Sarah
    Taskin, Tanjila
    Desai, Palak
    Vishwanatha, Jamboor K.
    Thompson, Erika L.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [47] India's Clinical Trial Regulatory Changes, Indian Researcher's Awareness of Recently Changed Regulations, and the Impact of the New Drugs and Clinical Trial Rules: A Review
    Vennu, V.
    Saini, P. P.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 82 (05) : 726 - 740
  • [48] Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics
    M H Tuszynski
    J D Steeves
    J W Fawcett
    D Lammertse
    M Kalichman
    C Rask
    A Curt
    J F Ditunno
    M G Fehlings
    J D Guest
    P H Ellaway
    N Kleitman
    P F Bartlett
    A R Blight
    V Dietz
    B H Dobkin
    R Grossman
    A Privat
    Spinal Cord, 2007, 45 : 222 - 231
  • [49] Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion exclusion criteria and ethics
    Tuszynski, M. H.
    Steeves, J. D.
    Fawcett, J. W.
    Lammertse, D.
    Kalichman, M.
    Rask, C.
    Curt, A.
    Ditunno, J. F.
    Fehlings, M. G.
    Guest, J. D.
    Ellaway, P. H.
    Kleitman, N.
    Bartlett, P. F.
    Blight, A. R.
    Dietz, V.
    Dobkin, B. H.
    Grosman, R.
    Privat, A.
    SPINAL CORD, 2007, 45 (03) : 222 - 231
  • [50] The ethics of a clinical trial when the protocol clashes with international guidelines
    Lan, N. T. N.
    Thu, N. T. N.
    Duc, N. H.
    Lan, N. N.
    Lien, T. T. X.
    Dung, N. H.
    Taburet, A-M.
    Laureillard, D.
    Borand, L.
    Quillet, C.
    Lagarde, D.
    Pym, A.
    Connolly, C.
    Lienhardt, C.
    Rekacewicz, C.
    Harries, A. D.
    PUBLIC HEALTH ACTION, 2013, 3 (02): : 97 - 102